icon-folder.gif   Conference Reports for NATAP  
 
  3rd International Workshop on HIV & Women
January 14-15, 2013
Toronto
Back grey_arrow_rt.gif
 
 
 
STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF is Safe and Well-Tolerated with Efficacy Comparable to Efavirenz/Emtricitabine/Tenofovir DF in ART-Na´ve Females at Week 96
 
 
  Reported by Jules Levin
 
4th International Workshop on HIV and Women, from Adolescence through Menopause January 13-14, 2014 Washington DC, USA
 
C Creticos1, C McDonald2, S Segal-Maurer3, I Brar4, B Wade5, C Brinson6, W Garner7, D Porter7, T Fralich7, J DeMorin7, O Lugo-Torres7, E Elbert7 1Howard Brown Health Center, Chicago, IL; 2Tarrant County Infectious Disease, Fort Worth, TX, USA; 3New York Hospital Queens, Flushing, NY, USA; 4Henry Ford Hospital, Detroit, MI, USA; 5Center for Prevention/Treatment, Pensacola, FL, USA; 6Red River Family Practice, Austin, TX, USA; 7Gilead Sciences, Foster City, CA, USA

Womens1.gif

Womens2.gif

Womens3.gif

Womens4.gif

Womens5.gif

Womens6.gif

Womens7.gif

Womens8.gif

Womens9.gif

Womens10.gif

Womens11.gif